Lengthy Antimalarial Activity of Atovaquone in Human Plasma following Atovaquone-Proguanil Administration

This publication has 12 references indexed in Scilit:

• Persistence of atovaquone in human sera following treatment: Inhibition of Plasmodium falciparum development in vivo and in vitro
  2003
• Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum
  The Lancet, 2002
• Absence of an interaction between artesunate and atovaquone - proguanil
  European Journal of Clinical Pharmacology, 1999
• Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria.
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1998
• Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum*
  Clinical Pharmacology & Therapeutics, 1997
• Population pharmacokinetics of proguanil in patients with acute P. falciparum malaria after combined therapy with atovaquone
  British Journal of Clinical Pharmacology, 1996
• Pharmacokinetics of proguanil in malaria patients treated with proguanil plus atovaquone.
  1996
• Clinical Studies of Atovaquone, Alone or in Combination with other Antimalarial Drugs, for Treatment of Acute Uncomplicated Malaria in Thailand
  The American Journal of Tropical Medicine and Hygiene, 1996
• Examination of some factors responsible for a food‐induced increase in absorption of atovaquone.
  British Journal of Clinical Pharmacology, 1994
• The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism.
  British Journal of Clinical Pharmacology, 1990